Apple did it again: Despite all the worries about China, the consumer tech giant hit back with beats on the top and bottom lines, sending shares up 6% in after-hours trading. This is why we own it. This is why we don’t trade it. Apple’s fiscal first quarter revenue hit …
Stanley Black & Decker overcame a soft demand environment to deliver a top and bottom line beat Thursday, but the stock is falling because the toolmaker simply reiterated its guidance. That’s a fate shared by home-improvement peers and many other companies this earnings season. We added to our position on …
My top 10 things to watch Thursday, May 2 The S & P 500 and Nasdaq are higher Thursday, one day after they surrendered their post-Federal Reserve meeting gains and closed modestly lower. After leaving interest rates unchanged, Fed chief Jerome Powell essentially ruled out a hike as central bankers’ …
Estee Lauder tumbled Wednesday as investors focused on the company’s weak fiscal fourth-quarter outlook instead of its strong third-quarter numbers. We’re looking deeper and believe that business fundamentals and profit are set to improve into the next fiscal year. Revenue in the three months ended March 31 advanced 5% year …
Starbucks shares plummeted Tuesday evening by roughly 11.5% after the coffee giant delivered a much weaker-than-expected quarter. The company also cut its outlook for fiscal 2024, leaving little room for optimism of a quick rebound in traffic at its stores. Revenue fell 2% year over year to $8.56 billion in …
Eaton delivered beats on the top and bottom lines on Tuesday but saw its stock slip as investors took profits after a 30% gain so far this year. We see a buying opportunity. Revenue increased 8% year over year organically to a new first-quarter record of $5.94 billion, outpacing analyst …
Eli Lilly ‘s raised guidance stole the show Tuesday, offsetting mixed first-quarter results and propelling shares higher by nearly 6%. The numbers leave little doubt that the long-term Eli Lilly success story remains intact, as demand for its new diabetes and obesity drugs, Mounjaro and Zepbound, outstrips supply. Revenue in …
The major U.S. stock indexes closed higher for the week, with the S & P 500 and Nasdaq Composite breaking multiweek losing streaks. Earnings drove the action, despite some less-than-ideal macroeconomic reports on economic growth and inflation. Meta Platforms ‘ report gave the market a bit of a scare Wednesday …
Microsoft delivered picture-perfect earnings after the bell Thursday, calming the market’s brief fears about runaway spending on AI infrastructure without the cloud revenues to show for it. Revenue increased about 17% year over year, to $61.86 billion, beating the Street consensus estimate of $60.8 billion, according to data from LSEG. …
Stocks tumbled Thursday after the latest U.S. economic data showed a sharp slowdown in growth and pointed to persistent inflation. The Dow Jones Industrial Average slid 352 points, or 0.9%, weighed down by steep declines in Caterpillar and IBM. The S&P 500 dropped 0.5%, and the Nasdaq Composite lost 0.7%. …